Rocket Pharmaceuticals

Company snapshot

Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for our mission and making a difference for

• 1 approved product(s) across US/EU regulatory metadata.
• 11 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Rocket Pharmaceuticals. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Rocket Pharmaceuticals.

1. Jun 8, 2026 Clinical update

   RP-A701-0125 — Phase 1

2. Jun 8, 2026 Clinical update

   Clostridium butyricum (live) Tablets(Meiya) — Unknown

3. Jun 5, 2026 Clinical update

   RP-L401 — Phase 1

4. Jun 5, 2026 Clinical update

   RP-L102 — Phase 2

5. Jun 5, 2026 Clinical update

   RP-A601 — Phase 1

View all clinical trial activity →

• What is Rocket Pharmaceuticals?

  Rocket Pharmaceuticals is a pharma organization headquartered in Cranbury, USA. It trades on NYSE under ticker RCKT. Primary therapeutic focus areas include Rectal Cancer, Fanconi Anemia, Danon Disease, PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), Dilated Cardiomyopathy (DCM).

• Is Rocket Pharmaceuticals publicly traded?

  Yes. Rocket Pharmaceuticals is listed with ticker RCKT on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Rocket Pharmaceuticals develop or market?

  We link 10 drug profile(s) where Rocket Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/rocket-pharmaceuticals-inc#company-drugs.

• What are the latest developments for Rocket Pharmaceuticals?

  In the last 12 months our linked public records show 11 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Rocket Pharmaceuticals focus on?

  Rocket Pharmaceuticals focuses on Rectal Cancer, Fanconi Anemia, Danon Disease based on our analysis of their pipeline programs and drug development activities.